Table of Contents Table of Contents
Previous Page  53 / 264 Next Page
Information
Show Menu
Previous Page 53 / 264 Next Page
Page Background

The natural history of MD is highly variable, which can

make it difficult to discern differences between treatment

and therapeutic effects. The natural history of an individual

patient would be difficult to take into account when analyz-

ing data from interventions, but this factor may explain the

variation seen in the outcomes reported in the studies we

reviewed. Moreover, we cannot ascertain the percentage of

patients who experience spontaneous symptom improvement

without the use of diuretic therapy. The natural history of

MD lends itself to spontaneous recovery from symptoms

without any intervention. Only 2 of our sources were RCTs

in design with a placebo as control.

8,11

Patients in these pla-

cebo groups did experience symptom improvement,

although this was not significant in either RCT. Last, we

suspect that publication bias may also explain the relative

frequency of positive results reported by the compiled stud-

ies in this review. It is probable that studies with negative

results either have not been submitted or were not accepted

for publication.

Conclusion

Multiple low-evidence-level studies report that oral diuretic

therapy may be beneficial in the medical management of MD.

If feasible, placebo-controlled studies will be required to fur-

ther substantiate these claims. Improvement in vertigo episode

frequency was often reported, with less convincing evidence

for improvement in hearing outcomes. These conclusions are

mitigated by multiple limitations, including the natural history

of MD, study design, and the possibility of publication bias.

Further investigation of the pathophysiology of MD will be

essential for providing tailored direction for established and

new therapies. Attention will need to be paid to the natural his-

tory of MD to determine true treatment effects.

Acknowledgments

We thank the Canadian Medical Association reference librarians

for their assistance in constructing the MEDLINE literature review

algorithm.

Author Contributions

Matthew G. Crowson

, project design, data collection, data analy-

sis, manuscript preparation, drafting, final approval, accountability

for all aspects of the work;

Aniruddha Patki

, Project design, Data

analysis, drafting, final approval, accountability for all aspects of

the work;

Debara L. Tucci

, Project design, drafting, final

approval, accountability for all aspects of the work

Disclosures

Competing interests:

Debara L. Tucci, consult for Otonomy

(chair, Data and Safety Monitoring Board).

Sponsorships:

None.

Funding source:

None.

References

1. Harris JP, Alexander TH. Current-day prevalence of Meniere’s

syndrome.

Audiol Neurootol

. 2010;15:318-322.

2. American Academy of Otolaryngology—Head and Neck

Foundation. Committee on Hearing and Equilibrium guidelines

for the diagnosis and evaluation of therapy in Meniere’s dis-

ease.

Otolaryngol Head Neck Surg

. 1995;113:181-185.

3. Gibson WP. Hypothetical mechanism for vertigo in Meniere’s

disease.

Otolaryngol Clin North Am

. 2010;43:1019-1027.

Table 7.

Mechanisms of Action for Selected Diuretic Agents.

a

Agent

Mechanism of Action

Acetazolamide

Reversible inhibition of the enzyme carbonic anhydrase resulting in reduction of hydrogen ion

secretion at renal tubule and an increased renal excretion of sodium, potassium, bicarbonate, and

water. Decreases production of aqueous humor and inhibits carbonic anhydrase in the central

nervous system to retard abnormal and excessive discharge from its neurons.

Chlorthalidone

Sulfonamide-derived diuretic that inhibits sodium and chloride reabsorption in the cortical-diluting

segment of the ascending loop of Henle.

Hydrochlorothiazide

Inhibits sodium reabsorption in the distal tubules causing increased excretion of sodium and water as

well as potassium and hydrogen ions.

Isosorbide

Osmotic diuretic with properties similar to those of mannitol.

Nimodipine

Nimodipine is a dihydropyridine calcium channel blocker that has the general properties of

nifedipine, which includes vasodilatation, with reduced peripheral resistance, blood pressure, and

afterload; increased coronary blood flow; and a reflex increase in heart rate. Additional evidence

suggests a diuretic action of calcium channel blockers through interference with renal and

extrarenal systems involved in the regulation of physiologic fluid and electrolyte balance.

35

Triamterene

Blocks epithelial sodium channels in the late distal convoluted tubule and collecting duct, which

inhibits sodium reabsorption from the lumen. This effectively reduces intracellular sodium,

decreasing the function of Na

1

/K

1

ATPase, leading to potassium retention and decreased calcium,

magnesium, and hydrogen excretion.

a

Source: Lexicomp,

34

unless otherwise stated.

Crowson et al

32